Next Article in Journal
Response Surface Methodology for Optimization of Process Parameters and Antioxidant Properties of Mulberry (Morus alba L.) Leaves by Extrusion
Next Article in Special Issue
Evaluation of Metabolite Profiles of Ginseng Berry Pomace Obtained after Different Pressure Treatments and Their Correlation with the Antioxidant Activity
Previous Article in Journal
NMR Study of Intercalates and Grafted Organic Derivatives of H2La2Ti3O10
Previous Article in Special Issue
Anti-Angiogenic Properties of Ginsenoside Rg3
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 25
Issue 22
10.3390/molecules25225230
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Alleviation of Ulcerative Colitis Potentially through th1/th2 Cytokine Balance by a Mixture of Rg3-enriched Korean Red Ginseng Extract and Persicaria tinctoria

by
Evelyn Saba
1,
Yuan Yee Lee
2,
Man Hee Rhee
2,* and
Sung-Dae Kim
3,*
1
Department of Veterinary Biomedical Sciences, Faculty of Veterinary and Animal Sciences, Pir Mehr Ali Shah Arid Agriculture University, Rawalpindi 46000, Pakistan
2
Department of Veterinary Medicine, College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Korea
3
Research Center, Dongnam Institute of Radiological and Medical Sciences, Busan 46033, Korea
*
Authors to whom correspondence should be addressed.
Molecules 2020, 25(22), 5230; https://doi.org/10.3390/molecules25225230
Submission received: 29 September 2020 / Revised: 2 November 2020 / Accepted: 3 November 2020 / Published: 10 November 2020
(This article belongs to the Special Issue Current Trends in Ginseng Research)
Browse Figures
Review Reports Versions Notes

Abstract

:
Ginseng is a vastly used herbal supplement in Southeast Asian countries. Red ginseng extract enriched with Rg3 (Rg3-RGE) is a formula that has been extensively studied owing to its various biological properties. Persicaria tinctoria (PT), belonging to the Polygonaceae family, has also been reported for its anti-inflammatory properties. Ulcerative colitis (UC) is inflammation of the large intestine, particularly in the colon. This disease is increasingly common and has high probability of relapse. We investigated, separately and in combination, the effects of Rg3-RGE and PT using murine exemplary of UC induced by DSS (Dextran Sulfate Sodium). For in vitro and in vivo experiments, nitric oxide assay, qRT-Polymerase Chain Reaction (PCR), Western blot, ulcerative colitis introduced by DSS, Enzyme Linked Immunosorbent Assay (ELISA), and flow cytometry analysis were performed. The results obtained demonstrate that treatment with Rg3-RGE + PT showed synergism to suppress inflammation (in vitro) in RAW 264.7 cells via mitogen-activated protein kinase and nuclear factor κB pathways. Moreover, in C57BL/6 mice, this mixture exhibits strong anti-inflammatory effects in restoring colon length, histopathological damage, pro-inflammatory mediators, and cytokines amount, and decreasing levels of NLRP3 inflammasome (in vivo). Our results recommend that this mixture can be used for the prevention of UC as a prophylactic/therapeutic supplement.

Graphical Abstract

1. Introduction

Inflammatory bowel disease (IBD) is a term that describes two intestinal abnormalities, ulcerative colitis (UC) and Crohn’s disease (CD). Severe abdominal discomfort including hematochezia, diarrhea, and pain are characteristic manifestations of IBD. In the past few years, this disease has attracted great attention especially in developed countries, with reports indicating that greater than 1 million humans suffered from IBD in the US only [1,2]. An inefficient intestinal epithelial barrier and imbalance in the commensal microflora are responsible for IBD disease symptoms. Moreover, microscopically, IBD is demonstrated by extensive movement of neutrophils, monocytes and many types of lymphocytes in the intestinal epithelium which in turn release pro-inflammatory mediators and cytokines that aggravate inflammation. If left unresolved, chronic epithelial damage and even colorectal cancer (CRC) may occur [3].
UC, a form of IBD, occurs as a consequence of imbalance of T-helper (Th) cell types 1 and 2. Previous data have shown that a shift of balance toward Th2 cell cytokine production occurs during UC, whereas in CD, there is a bias toward Th1 cell cytokine production [4]. To date, the exact mechanism for the development of UC and CD is yet to be elucidated since the etiological factors responsible for both IBD forms are numerous; they range from the intestinal microenvironment to the general outer macro-environment and genetic susceptibility [5]. Inflammasomes are multiprotein oligomers that are responsible for producing pro-inflammatory cytokines. Nod-like receptor family pyrin domain-1 containing 3 (NLRP3) are the pattern-recognition receptors (PRR) that constitute inflammasomes, with a major part in the development of colitis via secreting pro-inflammatory cytokines [6,7].
In the Korean peninsula, Panax ginseng is used extensively as an herbal supplement for its therapeutic and preventive effects. Its name Panax has been given to ginseng because it is derived from “panacea” which means cure for all; this also includes the beneficial effects of ginseng in almost all disease conditions [8,9]. The active components called ginsenosides have biological activities of ginseng. To date, numerous ginsenosides have been discovered and used in experiments due to their specific biological activities [10]. Among them, Rg3 is a top-priority ginsenoside as it elicits strong biological properties in many ailments including hypertension, inflammation, and cancers [11,12]. Another beneficial herb, Persicaria tinctoria (PT), is known for its anti-inflammatory and antioxidant characteristics [13].
To date, however, a study examining the effects of Rg3-RGE and PT on intestinal disease such as colitis has not been performed. Therefore, we researched to find the combined effects of Rg3-RGE and PT on the colitis induced by DSS in a murine model.

2. Results

2.1. Bioactive Compounds in Rg3-RGE and PT

We investigated the bioactive compounds of Rg3-RGE via HPLC analysis and PT via UPLC–QTofMS analysis. The chromatogram for Rg3-RGE is shown in Figure 1A, with peaks labeled with the corresponding ginsenosides. The chromatogram for PT is shown in Figure 1B and the information for each peak is summarized in Table 1.

2.2. Rg3-RGE + PT Synergistically Attenuated LPS-Induced Inflammation

The basic endotoxin from the outer layer of Gram-negative bacteria, lipopolysaccharide (LPS), evokes a variety of inflammatory responses such as nitric oxide (NO) production, increased levels of arachidonic acid, and the stimulation and release of cytokines and chemokines. NO production is regarded as the defensive action of cells toward endotoxic shock [14]; however, its excessive stimulation can lead to cellular death, implying that NO levels should be controlled to prevent cytotoxicity. In this experiment, it is demonstrated that Rg3-RGE + PT showed synergism and faded the levels of NO in RAW 264.7 cells with no cytotoxicity (Figure 2A,B).

2.3. Effects of Rg3-RGE + PT on the Expression of Pro-Inflammatory Mediators and Cytokines at the Transcriptional and Translational Levels

The expression of pro-inflammatory mediators and cytokines are found to serve as a major response to the biological system to inflammation [15]. That is why we determined whether Rg3-RGE + PT in RAW 264.7 cells could affect the pro-inflammatory cytokine expression. Synergism with Rg3-RGE + PT significantly abolished the expression of iNOS, COX-2, IL-1β, IL-6 and TNF-α mRNA as shown in Figure 3A,B. In addition, iNOS and COX-2 translational levels were inhibited (as shown in Figure 3C,D).

2.4. Signal Transduction of Rg3-RGE + PT via NF-κB and Mitogen-Activated Protein Kinase (MAPK) Pathways

In inflammatory signaling, NF-κB serves as a top-priority pathway which is responsible for a vast array of transcription factors and genes associated with immunity, stress, and inflammation. When the ligand–receptor interaction occurs, transforming growth factor beta activated kinase 1 (TAK1) phosphorylation results in downstream activation of the TAK1 factor. The phosphorylated TAK1 then further travels downstream and activates IKKα/β resulting in its phosphorylation and IκBα activation. Phosphorylated IκBα then frees NF-κB which then translocates to the nucleus, initiating the inflammatory pathway [16]. Evidently from Figure 4A,B, Rg3-RGE + PT in macrophages inhibited phosphorylation of NF-κB along all its upstream factors in vitro.
The pathway of mitogen-activated protein kinase (MAPK) is another crucial pathway for cell response to stress and is co-stimulated to evoke an inflammatory response with NF-κB pathway [17]. As with the NF-κB pathway, it has several factors whose subsequent inflammation is mediated by phosphorylation. Therefore, we evaluated the effects of Rg3-RGE + PT on the level of expressions of the factors involved in the MAPK pathway. As shown in Figure 4C,D, Rg3-RGE + PT inhibited the phosphorylation of both upstream and downstream factors, meaning we had produced a potent anti-inflammatory mixture.

2.5. Preventive Role of Rg3-RGE + PT in DSS-Induced Colitis

Investigating the preventive influence of Rg3-RGE + PT on colitic mice caused by DSS, we treated mice with the two extracts alone and combined, and with a positive control (sulfasalazine) for 7 days. After 7 days, colon was extracted, and its length measured as shown in Figure 5A,B. Normal length was retained in the mixture-treated group; however, Rg3-RGE, PT, and the mixture recovered the weight of mice, which severely decreased due to DSS treatment as shown in Figure 5C. Disease activity index (DAI) was also found to be efficiently recovered in the mixture group as shown in Figure 5D. In addition, the histological damage as loss of epithelial cell integrity, thickening of the mucosal wall and infiltration of inflammatory cells in the colon tissue, as clearly observed in the DSS community, were reversed positively by treatment with the mixture (Figure 5E). Histopathological lesions in the colon tissue were classified according to the scoring method given by Geoboes et al. [18] as shown in Figure 5F.

2.6. Effects on Cytokine Production in DSS-Induced Colitis Mice

To investigate the expression of cytokines in mice model, plasma was extracted from DSS-induced colitis mice and level of expression of pro-inflammatory mediators and cytokines (NO, IL-1β, IL-5, IL-13, and TNF-α) were verified. The positive control and mixture group significantly inhibited these levels when compared to the DSS group as shown in Figure 6A–E. A radar chart was plotted and it was shown that the combination of Rg3-RGE and PT is more potent in suppressing NO, TNF-α and IL-1β (Figure 6F).

2.7. Transcriptional Suppression of Pro-Inflammatory Mediators and Cytokines and Signal Transduction of Rg3-RGE + PT via NF-κB in Colon Tissue

To verify that RNA obtained from DSS-induced mice colon exhibited the same expression as macrophage cells, mRNA, and protein expression were demonstrated for iNOS, COX-2, IL-1β, IL-6 and TNF-α and NLRP3 (Figure 7A,B), the positive control and mixture-treated group had significant inhibition in pro-inflammatory mediators and cytokine expression at the transcriptional level. At the translational level (Figure 7C), NLRP3 and NF-κB inhibition strengthen our hypothesis that the mixture has targeted the NF-κB pathway for alleviation of inflammation.

2.8. Effects of Rg3-RGE + PT on Immune Cell Subtypes in Spleen

DSS decreased the number of CD4+ T-cells and regulatory T-cells (Tregs) as shown in Figure 8A. However, treatment with sulfasalazine (positive control), Rg3-RGE, and PT recovered the number of CD4+ T-cells and Treg cells; the number of B-cell subtypes remained the same as shown in Figure 8B. Samples treated with the mixture had a significant rise in the number of Treg cells (Figure 8A) and CD4+ T-cells (Figure 8C) which confirms its synergistic effect compared to individual treatment of Rg3-RGE and PT (Figure 8). Since CD4+ T-cells were highly elevated, we sought to investigate the differentiation of T-helper cells by examining secretion of IFN-γ related to Th1, and IL-4 related to Th2 in anti-CD3 stimulated splenocytes. As shown in Figure 9A, IFN-γ was elevated by treatment with DSS, and reduced by treatment with sulfasalazine, Rg3-RGE, and PT. As expected, the mixture of Rg3-RGE and PT strongly reversed IFN-γ secretion when compared with the control group, which indicates that differentiation of naïve CD4+ T-cells to Th1 cells had decreased; however, differentiation to Th2 cells increased (owing to increased secretion of IL-4; (Figure 9B)). However, we should perform T-cell negative purification to remove all other T-cells such as the Natural Killer (NK) cells which may also secrete IFN-γ for a more accurate detection of Th1 related IFN-γ detection. From our findings, there may be a possibility that the mixture enhanced the Th2 immune pathway and ameliorated DSS-induced colitis. However, more studies should be conducted to validate the expression of other Th1- and Th2-related cytokines to identify the exact mechanism of action.

3. Discussion

In animals, DSS-induced colitis is used extensively as a reference procedure to study colitis. DSS, a polysaccharide comprising of a negative charge and sulfate moiety, has a molecular weight ranging from 5–1400 kDa. It was reported that the most severe form of colitis that closely resembles human UC can result when treating water and 40–50 kDa DSS [19,20]. This model is therefore very frequently used owing to its austerity, consistency, swiftness, and tractability. Hence, we employed this inflammation model in our study to explore the influence of Rg3-enriched red ginseng extract and PT regarding colitis.
PT, a flowering plant belonging to the buckwheat family, is most commonly termed “Chinese indigo” or “Japanese indigo”. It is called indigo because it is commonly used as a dye that gives blue/indigo color in fabrics. In addition to its dying properties, its stems and leaves possess antiphlogistic, antipyretic, anti-inflammatory, and depurative properties. PT has beneficial effects especially in inflammation where it reduces the permeability of capillaries and elevates the phagocytosis rate of white blood cells. PT is also used for skin disorders such as pimples and freckles, and disease conditions such as mumps, erysipelas, infantile convulsions and choreoathetosis (ICCA) syndrome, and febrile condition in children [21,22,23].
Ginseng is the most widely consumed herb in Southeast Asian countries, owing to its outstanding health-promoting qualities. Rg3-RGE, also a commonly consumed extract in the Korean peninsula, has been extensively examined because of its positive influences on health [24]. Since much literature has presented the effect of different types of combination extracts on colitis, working in an additive or synergistic manner [11,25], we sought to combine PT and Rg3-RGE to verify their effects when combined over the DSS-induced colitis sample (model).
In response to noxious stimuli such as foreign invaders or inflammation-inducing agents such as LPS or DSS, the interaction of LPS with its toll-like receptor (TLR4) triggers a sequence of inflammatory factors (iNOS and COX-2) and cytokines (IL-1β, IL-6 and TNF-α) [26]. Previous literature has shown that the intensity of DSS introduced colitis in iNOS knockout mice or by treatment with specific iNOS inhibitors in mice was considerably inhibited [27]. In addition, immune-system hyper-activation terminates the release of pro-inflammatory cytokines such as IL-1β, IL-6, IL-5, IL-13, and TNF-α. The production of these chemicals requires timely management. Otherwise, they become major players in the erosion of intestinal epithelium [28]. As shown from our results, a combination of Rg3-RGE and PT synergistically hindered the interpretation of such pro-inflammatory mediators and cytokines in DSS-induced colitis mice’s macrophage cells, colon tissue, and plasma (Figure 2, Figure 3, Figure 5 and Figure 6).
We have previously reported the anti-inflammatory effects of Rg3-RGE [29], where mice induced with sepsis have been rescued. In that study, we have shown that Rg3-RGE has potently inhibited pro-inflammatory mediators and cytokines, and suppressed proteins in the NF-κB and MAPK pathway. In another study, we have reported that the anti-inflammatory effects of Rg3-RGE is mediated by the RXRα-PPARγ heterodimer [30]. Due to its potent anti-inflammatory effects, we sought to investigate whether its benefits can be further elevated by a combination with other herbs. PT has been reported for its antioxidant and anti-inflammatory activities [13]. Our findings in Figure 1B and Table 1 revealed that the PT contains kaempferol and quercetin, where both compounds were previously reported for its beneficial properties. Kaempferol is antitumor, antioxidant, and anti-inflammatory [31]. Quercetin has also been reported for its anti-inflammatory properties [32]. Hence, the ginsenoside Rg3 in Rg3-RGE, quercetin, and kaempferol and PT are known bioactive compounds in this mixture. Thus, our study suggests the synergism among these bioactive constituents, whose mechanism of action should be investigated in the future.
The primary pathway for inflammation elucidation is the conventional NF-κB pathway and the MAPK. Numerous studies have shown that suppression in these pathways is responsible for reduction with DSS-induced colitic mice [33,34]. Consistent with previous literature, our results have also shown that treatment with the mixture and single extracts inhibited the expression of NF-κB in both macrophage cells and colon tissue, and MAPK in macrophage cells (Figure 4 and Figure 7C).
NLRP3, the NOD-like receptor (NLR) family’s best-characterized member, interacts with an adaptor protein (apoptosis-associated speck as protein (ASC)). If triggered by noxious stimuli, NLRP3, ASC, and pro-caspase 1 homogenize into a single complex called the inflammatory NLRP3 which in turn cleaves pro-caspase 1; this cleavage causes IL-1β and IL-18 to mature [35]. Once secreted, both IL-1β and IL-18 are known sources to severe inflammation. NLRP3 has been extensively studied due to its involvement in intestinal disorders such as colitis [6,36]. Our results have also shown that the single extracts and mixture treatment suppressed the levels of NLRP3 both at the transcriptional and translational levels (Figure 7B,C).
Histologically, IBD is characterized by distortion of the cryptic epithelium, swelling, and thickening of mucosa and submucosa membranes and the excessive propagation of acute and chronic inflammatory cells (in mucosa and submucosa membranes) such as goblet cells of the intestinal lining [37]. Interestingly, the mixture of Rg3-RGE and PT remarkably recovered the intestinal damage caused by DSS treatment, or rather protected the colon from this disease. Colon shortening, which is also considered a hallmark for DSS-induced colitis in animal models, was recovered synergistically when mice were treated with the mixture (Figure 5).
Immune response initiation occurs when T-helper cells (CD4+) or Cytotoxic T lymphocyte (CTL; CD8+) recognize an antigen, most of which is of bacterial origin [38]. Neutrophils, macrophages, and CD8+ cells may be activated by the immune system’s failure to regulate T-cell responses. CD4+ and CD8+ cells divide physiologically into subpopulations of T-cells of Th1 and Th2; subtypes of Th1 cells are responsible for the secretion of IL-1, IL-2, IL-12, IL-18, TNF-α, and IFNγ. The elevation of these cytokines is mainly responsible for the clinical manifestations of UC and CD. However, bias against the release of Th2 cell cytokines (i.e., IL-4, IL-5, and IL-10) has been observed in UC. In addition, some studies have shown that Th2 cytokine release provides protection in mice with DSS-induced colitis [39,40]. Therefore, considering previous literature, our results have first shown the enhanced number of CD4+ cells and Tregs in splenocytes of mice (with DSS-induced colitis) (Figure 8A); second, Th1 cytokine (i.e., IFNγ) was found to be increased only in the DSS group and its levels decreased by Rg3-RGE + PT treatment (Figure 9A), whereas, Th2 cytokine, (i.e., IL-4) was remarkably enhanced by treatment with the mixture (Figure 9B). Our study and previous studies therefore support that a balance exists between Th1/Th2 cell cytokines in DSS introduced colitic mice. From the results obtained, it can be hypothesized as Rg3-RGE + PT protects mice from DSS-induced colitis by the IL-4 protective mechanism.

4. Materials and Methods

4.1. Chemicals and Reagents

Dulbecco’s Modified Eagle Medium (DMEM), Fetal bovine serum (FBS), streptomycin and penicillin were obtained from Welgene (Daegu, Republic of Korea). Primers shown in Table 1 were acquired from Bioneer (Daejeon, Republic of Korea). Lipopolysaccharide (LPS), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT), and dextran sulfate sodium (DSS) were from Sigma-Aldrich (Catalogue# 42867, Molecular weight is 40,000 Da, St. Louis, MA, USA). Antibodies for Western blot, iNOS (#2982), COX-2 (#4842), p-TAK1 (#4531), p-NFκB p65 (#3033), IRAK-1 (#4359), p-IKKα/β (#2697), p-IκBα (#2859), β-actin (#4967), T-ERK (#9102), p-ERK (#9101), T-JNK (#9252), p-JNK (#9251), T-p38 (#9212), p-p38 (#9211), NLRP3 (#15101), HRP-linked antibody (#7074) were all obtained from Cell Signaling Technology (Danvers, MA, USA). Antibodies conjugated with fluorescence for flow cytometry analysis, PE-Cy5 anti-CD3 (145-2C11; 553065), PE anti-CD4 (RM4-5; 553049), FITC anti-CD8 (53-6.7; 553031), FITC anti-CD25 (3C7; 558689), FITC anti-CD19 (ID3; 553785) and PerCP-Cy5.5 anti-CD69 (H1.2F3; 561931), and CD3e monoclonal antibody (145-2C11; 553058) were obtained from BD Biosciences (San Diego, CA, USA).

4.2. Sample Preparation

Rg3-enriched red ginseng extract was prepared and analyzed via HPLC according to our previous study [38] as shown in Figure 1A. PT was prepared by boiling the leaves of the plant with 70% Ethanol and thereafter a concentrated extract was prepared by condensation and later a powdered form was obtained by lyophilization. Thereafter, PT extract was analyzed via UPLC–QTofMS for its active components as shown in Figure 1B. Analysis was carried out using a UPLC system (Waters Corp; Milford, MA, USA). The analysis was conducted by injecting sample into an AQUITY UPLC® BEH C18 (2.1 × 100 mm × 1.7 μm) column. The mobile phase consisted of distilled water as solvent A, and acetonitrile as solvent B. The column was eluted with a gradient elution at a flow rate of 0.4 mL/min as stated: initial, solvent A 90%; solvent B 10%, 0–1 min, solvent A 90%; solvent B 10%, 1–11 min, solvent A 10%; solvent B 90%, 11–11:30 min, solvent A 0%; solvent B 100%, 11:30–13:40 min, solvent A 0%; solvent B 100%, 13:40–13:50 min, solvent A 90%; solvent B 10%, 13:50–15:00 min solvent A 90%; solvent B 10%.

4.3. Cell Culture

The murine macrophage cell line, RAW 264.7, from American Type Culture Collection (ATCC, Manassas, VA, USA) was cultured in DMEM supplemented with 8% FBS, 100 IU/mL penicillin and 100 μg/mL streptomycin sulfate; the cells were incubated in a humidified 5% CO2 atmosphere at 37 °C.

4.4. Nitric Oxide (NO) Assay

Nitric oxide was measured by the method for the Griess reaction assay. RAW 264.7 cells were seeded in a 96-well plate and incubated with or without LPS (0.1 μg/mL) in the absence or presence of Rg3-RGE + PT at indicated concentrations for 18 h. Remaining steps were done as reported in our previous study [41]. Briefly, supernatant was collected and added with Griess reagent for the detection of NO. Absorbance of the resulting solution was checked at an absorbance of 540 nm using a microplate reader (Versamax; Molecular Devices, San Jose, CA, USA).

4.5. Cell Viability (MTT) Assay

To determine the cytotoxic effects of samples, cell viability assay was performed using MTT reagent which was added to the culture medium at a final concentration of 0.1 mg/mL. After 4 h of incubation at 37 °C in 5% CO2, the resulting violet-colored crystals were dissolved in dimethyl sulfoxide (DMSO), 100 μL/well and the absorbance values measured at 560 nm using a microplate reader (Versamax; Molecular Devices, San Jose, CA, USA).

4.6. DSS-Induced Colitis Model and Ginseng Mixture Treatment Regimens

Male C57BL/6 mice (6–8 weeks old; 18–20 g) were purchased from Charles River (Orient Biotechnology, Gyeonggi-do, South Korea) and housed in a specific-pathogen-free barrier facility at 21 ± 2 °C with a relative humidity of 60 ± 10% under a 12h light and dark cycle. Feed and water were provided ad libitum. All animal care and experimental procedures were performed in accordance with internationally accepted guidelines on the use of laboratory animals (IACUC) and the protocols were approved by the Animal Care Committee of the College of Veterinary Medicine, Kyungpook National University, Daegu, Republic of Korea (January 18, 2018: approval number: KNU2018-002). For the experiment, mice were divided into 6 groups (n = 6 in each group) as follows: (1) control; (2) 3% DSS; (3) positive control, sulfasalazine (75 mg/kg) + DSS; (4) Rg3-RGE (20 mg/kg) + DSS; (5) PT (300 mg/kg) + DSS; and (6) mixture of Rg3-RGE + PT + DSS. All groups excluding group 1 were administered 3% DSS in drinking water ad libitum for 7 days after a period of acclimatization. Oral administration of sulfasalazine, Rg3-RGE, PT, and the mixture was initiated simultaneously on the same day as DSS administration. On day 7th of experiment, all mice were euthanized, and blood, colon, and spleen tissues collected for further experimentations.

4.7. RNA Extraction and Polymerase Chain Reaction (PCR)

RAW 264.7 cells were pretreated with or without Rg3-RGE + PT at the indicated concentrations for 30 min and then stimulated with LPS (0.1 μg/mL) for 18 h. Later steps were according to our previous study [37]. Briefly, total RNA was extracted and reverse transcribed with a kit to obtain the cDNA (Bioneer, Daejeon, Republic of Korea). Resultant cDNA undergoes polymerase chain reaction (PCR), and the PCR product was run on 1% ethidium bromide stained-agarose gel. Gel images were developed (General Electrics, Boston, MA, USA). Images were quantified with Image J version 1.53a (NIH, Montgomery County, MD, USA) and relatively compared with GAPDH, which was used as the housekeeping gene. Experiments were repeated three times. Colon of mice were subjected to qRT-PCR using Bio-Rad Real-Time Thermal Cycler CFX96 (Bio-Rad, Hercules, CA, USA). The PCR primer sequences are given in Table 2.

4.8. Western Blot Analysis

RAW 264.7 cells were treated with Rg3-RGE + PT or left untreated in the presence or absence of LPS (0.1 μg/mL). Later steps were according to our previously reported study [30]. Briefly, protein was extracted from cells and separated via 10% SDS-PAGE. Proteins were transferred to PVDF membranes, blocked, and incubated with the respective primary antibodies (1:1000). The next day, membranes were washed and incubated with secondary antibody (1:3000) for 75 min before developing in a gel developer (General Electrics, Boston, MA, USA).

4.9. Gross Examination of Colon and Disease Activity Index (DAI)

For the gross examination of colon, mice were sacrificed, and the colon was removed. The length was then measured and plotted on a graph. Weight measurement was performed every day for 7 days and mice were macroscopically observed for their general disposition, consistency of stool and presence of blood in stools (hematochezia). Thereafter, DAI, a combined score of weight loss, stool consistency, and presence of blood in stools, was determined according to Sann et al. [42].

4.10. Enzyme Linked Immunosorbent Assay (ELISA) for Cytokines

The levels of IL-5, IL-13, IL-1β and TNF-α in the plasma of DSS-induced colitis mice were measured using Mouse IL-5, Mouse IL-13, Mouse IL-1β and Mouse TNF-α Quantikine ELISA kits (R&D Systems, Minneapolis, MN, USA), respectively, according to the manufacturers protocols. All samples were analyzed in triplicates and normalized to the total protein content of the sample, expressed as pg/mg protein.

4.11. Hematoxylin and Eosin (H&E) Staining

After euthanasia, colon tissues were harvested in 10% Neutral buffered formalin and the tissues processed for basic H&E staining, using established protocols [43].

4.12. Fluorescent Antibody Cell Sorting (FACS)

The spleens from mice were lightly pulverized using a BD syringe plunger and passed through a cell strainer (pore size, 70 µm) into DPBS (Dulbecco’s phosphate buffered saline) and centrifuged at 245 g for 5 min at 20–25 °C. This experiment was further carried out according to our previously reported protocol [37]. Briefly, red blood cells were lysed and centrifuged to obtain splenocytes. Splenocytes were adjusted to 1 × 105 cells and stained with specific antibodies, and resuspended in FACS buffer (2% FBS in phosphate buffered saline). Lymphocytes were gated and analyzed with BD FACSAriaIIITM (BD Biosciences, San Jose, CA, USA). Unstained cells were used as a control for the negative population.

4.13. Estimation of Th1/Th2 Cytokines Using ELISA

Th1/Th2 cytokines (i.e., IL-4 and IFN-γ) were measured using ELISA. 96 well plates were coated with 0.5 µg/mL CD3e mAb before incubation with splenocytes overnight. The MoAbs-based mouse interleukin ELISA kits (R&D system, Minneapolis, MN, USA) was used the following day to determine their levels, according to manufacturer’s instructions.

4.14. Statistical Analysis

Data are presented as mean ± SD. One-way ANOVA (Analysis of variance) and Dunnett’s test were applied to statistically evaluate the data. Statistical analyses with *** p < 0.001 and ** p < 0.05 and * p < 0.01 were considered significant compared to LPS and DSS group; # p < 0.01 when compared to Rg3-RGE or PT alone.

5. Conclusions

To conclude, this is the first research to display the effects of Rg3-RGE, PT, and the combined mixture on DSS-induced colitis in mice, to our best knowledge. Synergistically, Rg3-RGE + PT inhibited expression of NO, iNOS, COX-2, IL-1β, IL-6, IL-5, IL-13, and TNF-α in the DSS-induced colitis mice’s macrophage cells, plasma, and colon tissue. In addition, these attenuating effects were acting through the NF-κB and MAPK, and suppressed by NLRP3. The Rg3-RGE + PT group experienced synergistic recovery of the macroscopic parameters (DAI, length of the colon, and weight loss) and colon microscopic lesions. Rg3-RGE + PT also up-regulated mice’s CD4+ cells, and the Th2 cytokine, IL-4, was identified as the target to protect mice from DSS-induced colitis.

Author Contributions

E.S. and S.-D.K. conceptualized and conducted all experiments and drafted the manuscript. Y.Y.L. partially conducted experiments and proofread the manuscript. M.H.R. supervised the study and proofread the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Research Foundation of Korea (2018R1D1A1A09083797).

Acknowledgments

We would like to thank our colleagues and students that provided support in this study.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Podolsky, D.K. Inflammatory Bowel Disease. N. Engl. J. Med. 2002, 347, 417–429. [Google Scholar] [CrossRef] [PubMed]
  2. Tontini, G.E.; Vecchi, M.; Pastorelli, L.; Neurath, M.F.; Neumann, H. Differential diagnosis in inflammatory bowel disease colitis: State of the art and future perspectives. World J. Gastroenterol. 2015, 21, 21–46. [Google Scholar] [CrossRef] [PubMed]
  3. Woo, J.K.; Choi, S.; Kang, J.-H.; Kim, D.E.; Hurh, B.-S.; Jeon, J.-E.; Kim, S.Y.; Oh, S.H. Fermented barley and soybean (BS) mixture enhances intestinal barrier function in dextran sulfate sodium (DSS)-induced colitis mouse model. BMC Complement. Altern. Med. 2016, 16, 498. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Zaki, H.; Boyd, K.L.; Vogel, P.; Kastan, M.B.; Lamkanfi, M.; Kanneganti, T.-D. The NLRP3 Inflammasome Protects against Loss of Epithelial Integrity and Mortality during Experimental Colitis. Immunity 2010, 32, 379–391. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Praengam, K.; Sahasakul, Y.; Kupradinun, P.; Sakarin, S.; Sanitchua, W.; Rungsipipat, A.; Rattanapinyopituk, K.; Angkasekwinai, P.; Changsri, K.; Mhuantong, W.; et al. Brown rice and retrograded brown rice alleviate inflammatory response in dextran sulfate sodium (DSS)-induced colitis mice. Food Funct. 2017, 8, 4630–4643. [Google Scholar] [CrossRef] [PubMed]
  6. Bauer, C.; Duewell, P.; Mayer, C.; Lehr, H.A.; Fitzgerald, K.A.; Dauer, M.; Tschopp, J.; Endres, S.; Latz, E.; Schnurr, M. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut 2010, 59, 1192–1199. [Google Scholar] [CrossRef] [Green Version]
  7. Zhou, W.; Liu, X.; Zhang, X.; Tang, J.; Li, Z.; Wang, Q.; Hu, R. Oroxylin A inhibits colitis by inactivating NLRP3 inflammasome. Oncotarget 2017, 8, 58903–58917. [Google Scholar] [CrossRef]
  8. Kiefer, D.; Pantuso, T. Panax ginseng. Am. Fam. Physician 2003, 68, 1539–1542. [Google Scholar]
  9. Lee, C.H.; Kim, J.-H. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. J. Ginseng Res. 2014, 38, 161–166. [Google Scholar] [CrossRef] [Green Version]
  10. Yao, Q.; Chen, C. Ginseng Compounds: An Update on their Molecular Mechanisms and Medical Applications. Curr. Vasc. Pharmacol. 2009, 7, 293–302. [Google Scholar] [CrossRef] [Green Version]
  11. Kim, S.M.; Lee, S.Y.; Cho, J.S.; Son, S.M.; Choi, S.S.; Yun, Y.P.; Yoo, H.S.; Yoon, D.Y.; Oh, K.-W.; Han, S.B.; et al. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-κB. Eur. J. Pharmacol. 2010, 631, 1–9. [Google Scholar] [CrossRef] [PubMed]
  12. Kim, B.-M.; Kim, D.-H.; Park, J.-H.; Na, H.-K.; Dong, Z. Ginsenoside Rg3 Induces Apoptosis of Human Breast Cancer (MDA-MB-231) Cells. J. Cancer Prev. 2013, 18, 177–185. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Kim, S.-J.; Jang, T.-W.; Kim, D.-W.; Park, J.H. Study on Antioxidant and Anti-inflammatory Activities of Persicaria tinctoria. Korea J. Herbol. 2015, 30, 17–24. [Google Scholar] [CrossRef]
  14. Coleman, J.W. Nitric oxide in immunity and inflammation. Int. Immunopharmacol. 2001, 1, 1397–1406. [Google Scholar] [CrossRef]
  15. Dinarello, C.A. Proinflammatory Cytokines. Chest 2000, 118, 503–508. [Google Scholar] [CrossRef] [PubMed]
  16. Li, Q.; Verma, I.M. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2002, 2, 725–734. [Google Scholar] [CrossRef] [PubMed]
  17. Zhang, W.; Liu, H.T. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 2002, 12, 9–18. [Google Scholar] [CrossRef]
  18. Geboes, K.; Riddell, R.; Öst, A.; Jensfelt, B.; Persson, T.; Löfberg, R. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 2000, 47, 404–409. [Google Scholar] [CrossRef] [Green Version]
  19. Okayasu, I.; Hatakeyama, S.; Yamada, M.; Ohkusa, T.; Inagaki, Y.; Nakaya, R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990, 98, 694–702. [Google Scholar] [CrossRef]
  20. Chassaing, B.; Aitken, J.D.; Malleshappa, M.; Vijay-Kumar, M. Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice. Curr. Protoc. Immunol. 2014, 104, 15.25.1–15.25.14. [Google Scholar] [CrossRef]
  21. Jang, H.-G.; Heo, B.-G.; Park, Y.S.; Namieśnik, J.; Barasch, D.; Katrich, E.; Vearasilp, K.; Trakhtenberg, S.; Gorinstein, S. Chemical Composition, Antioxidant and Anticancer Effects of the Seeds and Leaves of Indigo (Polygonum tinctorium Ait.) Plant. Appl. Biochem. Biotechnol. 2012, 167, 1986–2004. [Google Scholar] [CrossRef] [PubMed]
  22. Wiart, C. Medicinal Plants of China, Korea, and Japan; CRC Press: Boca Raton, FL, USA, 2012; p. 454. [Google Scholar]
  23. Angelini, L.G.; Tozzi, S.; O Di Nasso, N.N. Environmental Factors Affecting Productivity, Indican Content, and Indigo Yield inPolygonum tinctoriumAit., a Subtropical Crop Grown under Temperate Conditions. J. Agric. Food Chem. 2004, 52, 7541–7547. [Google Scholar] [CrossRef] [PubMed]
  24. Saba, E.; Kim, S.-H.; Kim, S.-D.; Park, S.-J.; Kwak, D.-M.; Oh, J.-H.; Park, C.-K.; Rhee, M.H. Alleviation of diabetic complications by ginsenoside Rg3-enriched red ginseng extract in western diet-fed LDL–/– mice. J. Ginseng Res. 2018, 42, 352–355. [Google Scholar] [CrossRef] [PubMed]
  25. Watanabe, T.; Yamamoto, T.; Yoshida, M.; Fujiwara, K.; Kageyama-Yahara, N.; Kuramoto, H.; Shimada, Y.; Kadowaki, M. The Traditional Herbal Medicine Saireito Exerts Its Inhibitory Effect on Murine Oxazolone-Induced Colitis via the Induction of Th1-Polarized Immune Responses in the Mucosal Immune System of the Colon. Int. Arch. Allergy Immunol. 2010, 151, 98–106. [Google Scholar] [CrossRef]
  26. Kumar, H.; Kawai, T.; Akira, S. Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 2009, 388, 621–625. [Google Scholar] [CrossRef]
  27. Cho, E.-J.; Shin, J.-S.; Noh, Y.-S.; Cho, Y.-W.; Hong, S.-J.; Park, J.-H.; Lee, J.Y.; Lee, J.-Y.; Lee, K.-T. Anti-inflammatory effects of methanol extract of Patrinia scabiosaefolia in mice with ulcerative colitis. J. Ethnopharmacol. 2011, 136, 428–435. [Google Scholar] [CrossRef]
  28. Kristensen, N.N.; Claesson, M.H. Future targets for immune therapy in colitis? Endocrine, Metab. Immune Disord. Drug Targets 2008, 8, 295–300. [Google Scholar] [CrossRef]
  29. Saba, E.; Jeong, D.; Irfan, M.; Lee, Y.Y.; Park, S.-J.; Park, C.-K.; Rhee, M.H. Anti-Inflammatory Activity of Rg3-Enriched Korean Red Ginseng Extract in Murine Model of Sepsis. Evid. Based Complement. Altern. Med. 2018, 2018, 6874692. [Google Scholar] [CrossRef] [Green Version]
  30. Saba, E.; Irfan, M.; Jeong, D.; Ameer, K.; Lee, Y.Y.; Park, C.-K.; Hong, S.-B.; Rhee, M.H. Mediation of antiinflammatory effects of Rg3-enriched red ginseng extract from Korean Red Ginseng via retinoid X receptor α-peroxisome-proliferating receptor γ nuclear receptors. J. Ginseng Res. 2018, 43, 442–451. [Google Scholar] [CrossRef]
  31. Wang, J.; Fang, X.; Ge, L.; Cao, F.; Zhao, L.; Wang, Z.; Xiao, W. Antitumor, antioxidant and anti-inflammatory activities of kaempferol and its corresponding glycosides and the enzymatic preparation of kaempferol. PLoS ONE 2018, 13, e0197563. [Google Scholar] [CrossRef]
  32. Lesjak, M.; Beara, I.; Simin, N.; Pintać, D.; Majkić, T.; Bekvalac, K.; Orčić, D.; Mimica-Dukić, N. Antioxidant and anti-inflammatory activities of quercetin and its derivatives. J. Funct. Foods 2018, 40, 68–75. [Google Scholar] [CrossRef]
  33. Zhang, Z.-L.; Fan, H.-Y.; Yang, M.-Y.; Zhang, Z.-K.; Liu, K. Therapeutic effect of a hydroxynaphthoquinone fraction on dextran sulfate sodium-induced ulcerative colitis. World J. Gastroenterol. 2014, 20, 15310–15318. [Google Scholar] [CrossRef] [PubMed]
  34. Docena, G.; Rovedatti, L.; Kruidenier, L.; Fanning, A.; Leakey, N.A.B.; Knowles, C.H.; Lee, K.; Shanahan, F.; Nally, K.; McLean, P.G.; et al. Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease. Clin. Exp. Immunol. 2010, 162, 108–115. [Google Scholar] [CrossRef]
  35. Menu, P.; Vince, J.E. The NLRP3 inflammasome in health and disease: The good, the bad and the ugly. Clin. Exp. Immunol. 2011, 166, 1–15. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Wu, X.-F.; Ouyang, Z.-J.; Feng, L.-L.; Chen, G.; Guo, W.-J.; Shen, Y.; Wu, X.-D.; Sun, Y.; Xu, Q. Suppression of NF-κB signaling and NLRP3 inflammasome activation in macrophages is responsible for the amelioration of experimental murine colitis by the natural compound fraxinellone. Toxicol. Appl. Pharmacol. 2014, 281, 146–156. [Google Scholar] [CrossRef] [PubMed]
  37. Deroche, T.C.; Xiao, S.-Y.; Liu, X. Histological evaluation in ulcerative colitis. Gastroenterol. Rep. 2014, 2, 178–192. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Neuman, M.G. Signaling for inflammation and repair in inflammatory bowel disease. Romanian J. Gastroenterol. 2004, 13, 309–316. [Google Scholar]
  39. Hundorfean, G.; Neurath, M.F.; Mudter, J. Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease. Inflamm. Bowel Dis. 2012, 18, 180–186. [Google Scholar] [CrossRef]
  40. Eichele, D.D.; Kharbanda, K.K. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J. Gastroenterol. 2017, 23, 6016–6029. [Google Scholar] [CrossRef]
  41. Saba, E.; Lee, Y.Y.; Kim, M.; Hyun, S.-H.; Park, C.-K.; Son, E.; Kim, D.-S.; Kim, S.-D.; Rhee, M.H. A novel herbal formulation consisting of red ginseng extract and Epimedium koreanum Nakai-attenuated dextran sulfate sodium-induced colitis in mice. J. Ginseng Res. 2020. [Google Scholar] [CrossRef]
  42. Sann, H.; Von Erichsen, J.; Hessmann, M.; Pahl, A.; Hoffmeyer, A. Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice. Life Sci. 2013, 92, 708–718. [Google Scholar] [CrossRef] [PubMed]
  43. Kim, E.-J.; Lee, H.-A.; Lee, B.-S.; Park, S.-J.; Kim, J.W. Platycodon grandiflorus alleviates DNCB-induced atopy-like dermatitis in NC/Nga mice. Indian J. Pharmacol. 2012, 44, 469–474. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Molecules 25 05230 g001 550
Figure 1. Bioactive compound analysis in Rg3-RGE and Persicaria tinctoria (PT). Chromatogram for the HPLC analysis of Rg3-RGE (A) with the respective ginsenosides identified as labeled on their respective peaks. UPLC–QTofMS analysis of PT and their identified peaks (B). Constituents of PT are summarized in Table 1.
Figure 1. Bioactive compound analysis in Rg3-RGE and Persicaria tinctoria (PT). Chromatogram for the HPLC analysis of Rg3-RGE (A) with the respective ginsenosides identified as labeled on their respective peaks. UPLC–QTofMS analysis of PT and their identified peaks (B). Constituents of PT are summarized in Table 1.
Molecules 25 05230 g001
Molecules 25 05230 g002 550
Figure 2. Suppression of nitric oxide (NO) by Rg3-RGE + PT. RAW 264.7 cells were pre-incubated with Rg3-RGE + PT for 30 min and then stimulated with LPS for 18 h. Cell supernatant was then mixed with equal amounts of Griess reagent and the NO production measured (A). Effects of Rg3-RGE + PT on cell viability were measured by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay (B). *** p < 0.001 is considered significant compared to LPS and # p < 0.01 compared to inhibition by only Rg3-RGE or PT. Values in bar graphs represent mean ± SD of three independent experiments. Triplicates were completed within 10 days.
Figure 2. Suppression of nitric oxide (NO) by Rg3-RGE + PT. RAW 264.7 cells were pre-incubated with Rg3-RGE + PT for 30 min and then stimulated with LPS for 18 h. Cell supernatant was then mixed with equal amounts of Griess reagent and the NO production measured (A). Effects of Rg3-RGE + PT on cell viability were measured by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay (B). *** p < 0.001 is considered significant compared to LPS and # p < 0.01 compared to inhibition by only Rg3-RGE or PT. Values in bar graphs represent mean ± SD of three independent experiments. Triplicates were completed within 10 days.
Molecules 25 05230 g002
Molecules 25 05230 g003 550
Figure 3. Rg3-RGE + PT hindered the expression of pro-inflammatory mediators and cytokines. RAW 264.7 cells were pre-incubated with Rg3-RGE + PT for 30 min and then stimulated with LPS for 18 h. Total RNA and proteins from cells were extracted and the mRNA and protein expression of iNOS, COX-2 and IL-1β, IL-6 and TNF-α determined by (A,B) RT-Polymerase Chain Reaction (PCR), and (C,D) Western blot. GAPDH (Glyceraldehyde 3-phosphate dehydrogenase) and β-actin were used as internal control. Images are representative of three independent experiments. Values in bar graphs represent mean ± SD of three independent experiments. *** p < 0.001, ** p < 0.05 and * p < 0.01 considered significant compared to LPS and # p < 0.01 compared to inhibition by only Rg3-RGE or PT. Triplicates for RT-PCR were completed within 10 days whereas Western blot analysis were completed within 3 weeks.
Figure 3. Rg3-RGE + PT hindered the expression of pro-inflammatory mediators and cytokines. RAW 264.7 cells were pre-incubated with Rg3-RGE + PT for 30 min and then stimulated with LPS for 18 h. Total RNA and proteins from cells were extracted and the mRNA and protein expression of iNOS, COX-2 and IL-1β, IL-6 and TNF-α determined by (A,B) RT-Polymerase Chain Reaction (PCR), and (C,D) Western blot. GAPDH (Glyceraldehyde 3-phosphate dehydrogenase) and β-actin were used as internal control. Images are representative of three independent experiments. Values in bar graphs represent mean ± SD of three independent experiments. *** p < 0.001, ** p < 0.05 and * p < 0.01 considered significant compared to LPS and # p < 0.01 compared to inhibition by only Rg3-RGE or PT. Triplicates for RT-PCR were completed within 10 days whereas Western blot analysis were completed within 3 weeks.
Molecules 25 05230 g003
Molecules 25 05230 g004 550
Figure 4. Signal transduction of Rg3-RGE + PT by the NF-κB and MAPK pathways. RAW 264.7 cells were pre-incubated with Rg3-RGE + PT extract for 30 min and then stimulated with LPS for 18 h. Nuclear and cytosolic proteins from cells were extracted by NE-PER® nuclear and cytosolic extraction reagents. β-actin was used as an internal control. Images are representative of three independent experiments. (A,B) NF-κB pathway, and (C,D) MAPK pathway. Values in bar graphs represent mean ± SD of three independent experiments. *** p < 0.001, ** p < 0.05 and * p < 0.01 is considered significant compared to LPS and # p < 0.01 compared to inhibition by only Rg3-RGE or PT. Triplicates for Western blot analysis were completed within 3 weeks.
Figure 4. Signal transduction of Rg3-RGE + PT by the NF-κB and MAPK pathways. RAW 264.7 cells were pre-incubated with Rg3-RGE + PT extract for 30 min and then stimulated with LPS for 18 h. Nuclear and cytosolic proteins from cells were extracted by NE-PER® nuclear and cytosolic extraction reagents. β-actin was used as an internal control. Images are representative of three independent experiments. (A,B) NF-κB pathway, and (C,D) MAPK pathway. Values in bar graphs represent mean ± SD of three independent experiments. *** p < 0.001, ** p < 0.05 and * p < 0.01 is considered significant compared to LPS and # p < 0.01 compared to inhibition by only Rg3-RGE or PT. Triplicates for Western blot analysis were completed within 3 weeks.
Molecules 25 05230 g004
Molecules 25 05230 g005 550
Figure 5. Improvement of colon length, disease activity index (DAI) and histopathological lesions by Rg3-RGE + PT treatment. C57BL/6 mice were given 3% DSS in drinking water for 7 days along with p.o. treatment of the extracts. After 7 days, mice were euthanized, and the colon tissue were extracted for macroscopic and microscopic lesion assessment. (A) Gross examination of colon length (B) Quantification of colon length. (C) % Change in the body weight of mice. (D) DAI. (E) Hematoxylin and Eosin (H&E) staining of colon tissues (1) Control, (2) DSS, (3) Sulfasalazine + DSS, (4) Rg3-RGE + DSS, (5) PT + DSS and (6) Rg3-RGE + PT + DSS. Scale bar = 100 µm. (F) Histopathological score for colon damage. *** p < 0.001 considered significant compared to DSS group and # p < 0.01 compared to inhibition by only Rg3-RGE or PT. Macroscopic analysis were conducted the same day of termination.
Figure 5. Improvement of colon length, disease activity index (DAI) and histopathological lesions by Rg3-RGE + PT treatment. C57BL/6 mice were given 3% DSS in drinking water for 7 days along with p.o. treatment of the extracts. After 7 days, mice were euthanized, and the colon tissue were extracted for macroscopic and microscopic lesion assessment. (A) Gross examination of colon length (B) Quantification of colon length. (C) % Change in the body weight of mice. (D) DAI. (E) Hematoxylin and Eosin (H&E) staining of colon tissues (1) Control, (2) DSS, (3) Sulfasalazine + DSS, (4) Rg3-RGE + DSS, (5) PT + DSS and (6) Rg3-RGE + PT + DSS. Scale bar = 100 µm. (F) Histopathological score for colon damage. *** p < 0.001 considered significant compared to DSS group and # p < 0.01 compared to inhibition by only Rg3-RGE or PT. Macroscopic analysis were conducted the same day of termination.
Molecules 25 05230 g005
Molecules 25 05230 g006 550
Figure 6. Rg3-RGE + PT abolished the expression of pro-inflammatory mediators and cytokines in plasma of DSS mice. Plasma from blood was extracted and the expression of NO, TNF-α, IL-1β, IL-13 and IL-5 were determined by Enzyme Linked Immunosorbent Assay (ELISA) and colorimetric assay (A–E) where (A) NO expression, (B) TNF-α expression, (C) IL-1β expression, (D) IL-13 expression, and (E) IL-5 expression. Radar chart for normalized data trend fitting analysis of the serum biomarkers (F). Values in bar graphs represent mean ± SD of three independent experiments. *** p < 0.001 and ** p < 0.05 were considered significant compared to DSS group and # p < 0.01 compared to inhibition by only Rg3-RGE or PT. ELISA were conducted within 48 h of termination.
Figure 6. Rg3-RGE + PT abolished the expression of pro-inflammatory mediators and cytokines in plasma of DSS mice. Plasma from blood was extracted and the expression of NO, TNF-α, IL-1β, IL-13 and IL-5 were determined by Enzyme Linked Immunosorbent Assay (ELISA) and colorimetric assay (A–E) where (A) NO expression, (B) TNF-α expression, (C) IL-1β expression, (D) IL-13 expression, and (E) IL-5 expression. Radar chart for normalized data trend fitting analysis of the serum biomarkers (F). Values in bar graphs represent mean ± SD of three independent experiments. *** p < 0.001 and ** p < 0.05 were considered significant compared to DSS group and # p < 0.01 compared to inhibition by only Rg3-RGE or PT. ELISA were conducted within 48 h of termination.
Molecules 25 05230 g006
Molecules 25 05230 g007 550
Figure 7. Inhibition of mRNA of pro-inflammatory cytokines, NLRP3 and NF-κB protein expression by Rg3-RGE + PT. Total RNA and proteins were extracted from colon tissue of DSS-treated mice. mRNA was subjected to qRT-PCR and the expression of pro-inflammatory mediators and cytokines determined by SYBR (Synergy Brand, Inc) green fluorescence. Nuclear and cytosolic proteins were extracted using NE-PER® Nuclear and cytosolic extraction reagents. (A,B) qRT-PCR for iNOS, COX-2, IL-1β, IL-6, TNF-α, IL-5, IL-13, and NLRP3. (C) Western blot for NLRP3 and NF-κB. β-actin was used as an internal control. Images are representative of three independent experiments. Values in bar graphs represent mean ± SD of three independent experiments. *** p < 0.001 was considered significant compared to DSS group and # p < 0.01 compared to inhibition by only Rg3-RGE or PT. Experiments were completed within one week of termination.
Figure 7. Inhibition of mRNA of pro-inflammatory cytokines, NLRP3 and NF-κB protein expression by Rg3-RGE + PT. Total RNA and proteins were extracted from colon tissue of DSS-treated mice. mRNA was subjected to qRT-PCR and the expression of pro-inflammatory mediators and cytokines determined by SYBR (Synergy Brand, Inc) green fluorescence. Nuclear and cytosolic proteins were extracted using NE-PER® Nuclear and cytosolic extraction reagents. (A,B) qRT-PCR for iNOS, COX-2, IL-1β, IL-6, TNF-α, IL-5, IL-13, and NLRP3. (C) Western blot for NLRP3 and NF-κB. β-actin was used as an internal control. Images are representative of three independent experiments. Values in bar graphs represent mean ± SD of three independent experiments. *** p < 0.001 was considered significant compared to DSS group and # p < 0.01 compared to inhibition by only Rg3-RGE or PT. Experiments were completed within one week of termination.
Molecules 25 05230 g007
Molecules 25 05230 g008 550
Figure 8. Effects of Rg3-RGE + PT on immune cell subtypes in the spleen. (A) Percentage of CD4+ and CD8+ cells, (B) CD19+ cells and (C) CD4+CD25+ cells in the spleen. * indicates a significance of p < 0.01 for treatment group when compared to the DSS-treated group. Values in bar graphs represent mean ± SD of four independent experiments. Analysis was conducted on the same day of termination.
Figure 8. Effects of Rg3-RGE + PT on immune cell subtypes in the spleen. (A) Percentage of CD4+ and CD8+ cells, (B) CD19+ cells and (C) CD4+CD25+ cells in the spleen. * indicates a significance of p < 0.01 for treatment group when compared to the DSS-treated group. Values in bar graphs represent mean ± SD of four independent experiments. Analysis was conducted on the same day of termination.
Molecules 25 05230 g008
Molecules 25 05230 g009 550
Figure 9. Effects of Rg3-RGE + PT on lymphokine secretion. (A) Splenocyte supernatant levels of IFN-γ in the Sulfasalazine, Rg3-RGE, PT and Rg3-RGE + PT groups as determined by ELISA. (B) Splenocyte supernatant levels of IL-4 in the Rg3-RGE + PT group as determined by ELISA *** p < 0.001, ** p < 0.05 and * p < 0.01 when compared to the DSS-treated group and # p < 0.01 compared to the inhibition by only Rg3-RGE or PT. Values in bar graphs represent mean ± SD of four independent experiments. Experiments were conducted within 72 h of termination.
Figure 9. Effects of Rg3-RGE + PT on lymphokine secretion. (A) Splenocyte supernatant levels of IFN-γ in the Sulfasalazine, Rg3-RGE, PT and Rg3-RGE + PT groups as determined by ELISA. (B) Splenocyte supernatant levels of IL-4 in the Rg3-RGE + PT group as determined by ELISA *** p < 0.001, ** p < 0.05 and * p < 0.01 when compared to the DSS-treated group and # p < 0.01 compared to the inhibition by only Rg3-RGE or PT. Values in bar graphs represent mean ± SD of four independent experiments. Experiments were conducted within 72 h of termination.
Molecules 25 05230 g009
Table
Table 1. Constituents of PT analyzed via UPLC–QTofMS analysis.
Table 1. Constituents of PT analyzed via UPLC–QTofMS analysis.
Peak No.ESI-MS
RT (min)		UV (nm)Detected Ion (m/z) [M−H]−Calculated Ion (m/z) [M−H]−FragmentsMolecular FormulaIdentification
13.37254, 351477.0648477.0669301C21H18O13Quercetin-3-O-β-d-glucuronide
23.53254, 354607.1312607.1299505, 463, 301C27H28O16Quercertin-3-O-[6′′-O-(3-hydroxy-3-methylglutaryl)-β-d-glucopyranoside]
33.70268, 338477.1031477.1033315, 299C22H22O12Isorhamnetin-3-O-β-d-glucopyranoside
43.86265, 346591.1360591.1350447, 285C27H28O15Kaempferol-3-O-[6′′-(3-hydroxy-3-methylglutaryl)-β-d-glucopyranoside]
54.51277, 339475.1005475.0877313C22H20O123,5,4′-Trihydroxy-6,7-methylenedioxyflavone-3-O-β-d-glucopyranoside
64.60277, 340619.1486619.1299475, 313C28H28O163,5,4′-Trihydroxy-6,7-methylenedioxyflavone-3-O-[6′′-(3-hydroxy-3-methylglutaryl)-
β-d-glucopyranoside]
74.70277, 339517.1122517.0982475, 313C24H22O133,5,4′-Trihydroxy-6,7-methylenedioxyflavone-3-O-[6′′-(acetyl)-β-d-glucopyranoside]
85.26274, 339531.0790531.0775471, 313C24H20O143,5,4′-Trihydroxy-6,7-methylenedioxyflavone-3-O-[2′′-(acetyl)-β-d-glucuronide]
96.24274, 351313.0327313.0348no fragmentC21H18O133,5,4′-Trihydroxy-6,7-methylenedioxyflavone
Table
Table 2. Primer sequences used in this study.
Table 2. Primer sequences used in this study.
GenePrimerOligonucleotide Sequence (5′-3′)Accession Number
GAPDHForward5′-CAATGAATACGGCTACAGCAAC-3′BC023196.2
Reverse5′-AGGGAGATGCTCAGTGTTGG-3′
iNOSForward5′-CCCTTCCGAAGTTTCTGGCAGCAGC-3′NM_001313922.1
Reverse5′-GGCTGTCAGAGCCTCGTGGCTTTGG-3′
COX-2Forward5′- CAAGACGCCACATCCCCTAT -3′LC061973.1
Reverse5′- ATTTAGTCGGCCTGGGATGG -3′
IL-1βForward5′-CAGGGTGGGTGTGCCGTCTTTC-3′NM_008361.4
Reverse5′-TGCTTCCAAACCTTTGACCTGGGC-3′
TNF-αForward5′-TTGACCTCAGCGCTGAGTTG-3′NM_001278601.1
Reverse5′-CCTGTAGCCCACGTCGTAGC-3′
IL-6Forward5′-GTACTCCAGAAGACCAGAGG-3′NM_001314054.1
Reverse5′-TGCTGGTGACAACCACGGCC-3′
IL-5Forward5′-GAAGTGTGGCGAGGAGAGAC-3′BC125366.1
Reverse5′- GCACAGTTTTGTGGGGTTTT-3′
IL-13Forward5′-AGCATGGTATGGAGTGTGGA-3′NM_008355.3
Reverse5′-TTGCAATTGGAGATGTTGGT-3′
NLRP3Forward5′-TGCTCTTCACTGCTATCAAGCCCT-3′NM_145827.4
Reverse5′-ACAAGCCTTTGCTCCAGACCCTAT-3′
Sample Availability: Samples of the compounds are available from the authors.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Saba, E.; Lee, Y.Y.; Rhee, M.H.; Kim, S.-D. Alleviation of Ulcerative Colitis Potentially through th1/th2 Cytokine Balance by a Mixture of Rg3-enriched Korean Red Ginseng Extract and Persicaria tinctoria. Molecules 2020, 25, 5230. https://doi.org/10.3390/molecules25225230

AMA Style

Saba E, Lee YY, Rhee MH, Kim S-D. Alleviation of Ulcerative Colitis Potentially through th1/th2 Cytokine Balance by a Mixture of Rg3-enriched Korean Red Ginseng Extract and Persicaria tinctoria. Molecules. 2020; 25(22):5230. https://doi.org/10.3390/molecules25225230

Chicago/Turabian Style

Saba, Evelyn, Yuan Yee Lee, Man Hee Rhee, and Sung-Dae Kim. 2020. "Alleviation of Ulcerative Colitis Potentially through th1/th2 Cytokine Balance by a Mixture of Rg3-enriched Korean Red Ginseng Extract and Persicaria tinctoria" Molecules 25, no. 22: 5230. https://doi.org/10.3390/molecules25225230

Article Metrics

Back to TopTop